amphotericin-b and Diabetes--Gestational

Over the last few decades, the incidence of invasive candidal infections in neonatal intensive care units has increased dramatically. Various complications, such as arthritis, endocarditis, meningitis, and endophthalmitis, have been reviewed. We present the case of a premature infant with systemic candidemia. Arthritis was discovered 6 months after completion of amphotericin B therapy, and was successfully treated with oral fluconazole for 6 weeks. We conclude that long-term follow-up is particularly important in patients with treated candidemia. To prevent complications, prolonged treatment with high-dose amphotericin B is suggested for systemic fungal infection, and oral fluconazole is an effective alternative for candidal arthritis.

Topics: Amphotericin B; Antifungal Agents; Arthritis; Candidiasis; Diabetes, Gestational; Female; Fluconazole; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Knee; Magnetic Resonance Imaging; Male; Pregnancy; Radiography; Treatment Outcome